NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lockheed Martin Corporation ("Lockheed Martin Corporation" or the "Company") (NYSE: LMT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lockheed Martin Corporation investors who were adversely affected by alleged securities fraud between January 23, 2024 and July 21, 2025. Follow the link below to get more information and be contacted by a member of our team: htt ...

Core Viewpoint - A class action securities lawsuit has been filed against Dow Inc. alleging securities fraud that negatively impacted investors between January 30, 2025, and July 23, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Dow Inc. overstated its ability to manage macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [2]. - It is alleged that the negative impacts of competitive pressures, declining global sales, and product oversupply on Dow's business were understated [2]. - The defendants' public statements are claimed to have been materially false and misleading throughout the relevant period [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Novo Nordisk A/S, alleging securities fraud that negatively impacted investors between May 7, 2025, and July 28, 2025 [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Novo Nordisk made misleading statements regarding its growth potential, particularly underestimating the impact of the personalization exception to the compounded GLP-1 exclusion and overstating the likelihood of patients switching to its branded alternatives [2]. - On July 29, 2025, Novo announced a reduction in its sales and profit outlook, attributing this to lower growth expectations for Wegovy and Ozempic due to competition and the persistent use of compounded GLP-1s [2]. - Following the announcement, Novo's stock price plummeted from $69.00 per share on July 28, 2025, to $53.94 per share on July 29, 2025, marking a decline of approximately 21.83% in one day [2]. Group 2: Legal Proceedings and Participation - Investors who suffered losses during the specified timeframe have until September 30, 2025, to request to be appointed as lead plaintiff in the lawsuit [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and participation does not require serving as a lead plaintiff [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against Lineage, Inc. due to alleged securities fraud affecting investors who purchased shares during the company's initial public offering on July 26, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors adversely affected by alleged false statements made by Lineage, Inc. regarding its financial health and business operations [2][3]. - Allegations include that Lineage was experiencing a decline in customer demand, leading to destocking of excessive inventory and a shift to leaner cold-storage inventories [3]. - The complaint states that Lineage had implemented unsustainable price increases prior to the IPO, which could not be maintained due to weakening demand [3]. - It is claimed that Lineage's financial results were materially impaired, contrary to representations made in the registration statement, which suggested stable revenue growth and high occupancy rates [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant time frame have until September 30, 2025, to request appointment as lead plaintiff in the lawsuit [4]. - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [4]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [5]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [5].

Core Viewpoint - Tronox Holdings plc is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 12, 2025, and July 30, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Tronox provided overly positive statements while concealing material adverse facts about its commercial division and forecasting processes, which ultimately led to declining sales and increased costs [2] - On July 30, 2025, Tronox reported a significant reduction in TiO2 sales for the second quarter, attributing the decline to a softer coatings season and heightened competition, leading to a lowered financial outlook and a 60% reduction in dividends [2] - Following the announcement, Tronox's stock price plummeted from $5.14 per share to $3.19 per share on July 31, 2025, marking a decline of approximately 38% in one day [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a 20-year history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Snap Inc. ("Snap" or the "Company") (NYSE: SNAP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Snap investors who were adversely affected by alleged securities fraud between April 29, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=168 ...

Core Viewpoint - Fly-E Group, Inc. is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between July 15, 2025, and August 14, 2025 [1][2] Company Performance - The lawsuit claims that Fly-E provided overly positive statements while concealing material adverse facts regarding the safety of its lithium batteries, which affected E-vehicle sales revenue [2] - On August 14, 2025, Fly-E reported a 32% decrease in net revenues, primarily due to a decline in total units sold, attributed to recent lithium-battery accidents involving E-Bikes and E-Scooters [2] - Following the revenue report, Fly-E's stock price plummeted from $7.76 per share to $1.00 per share on August 15, 2025, marking an approximate 87% decline in a single day [2] Legal Proceedings - Investors who suffered losses during the specified timeframe have until November 10, 2025, to request to be appointed as lead plaintiff in the lawsuit [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Charter Communications, Inc. alleging securities fraud that adversely affected investors during a specified period [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who purchased or acquired Charter securities, including call options and put options, between July 26, 2024, and July 24, 2025 [2]. - The complaint alleges that the defendants made false statements and concealed significant impacts related to the end of the Affordable Connectivity Program (ACP), which affected Internet customer declines and revenue [3]. - It is claimed that the company failed to manage the consequences of the ACP ending, leading to greater risks to business plans and earnings growth than reported [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until October 14, 2025, to request appointment as lead plaintiff, although participation does not require serving in this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - Nutex Health Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between August 8, 2024, and August 14, 2025, impacting investors adversely [1][2]. Group 1: Allegations and Impact - The lawsuit claims that Nutex Health Inc. made false statements and concealed information regarding its third-party vendor HaloMD, which allegedly engaged in fraudulent activities to defraud insurance companies [2]. - It is alleged that revenues from Nutex's engagement with HaloMD were unsustainable due to the fraudulent conduct, leading to overstated business and financial prospects [2]. - The company reportedly overstated its remediation of material weaknesses in internal controls over financial reporting, affecting its ability to account for stock-based compensation obligations correctly [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until October 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating a no-cost participation model [3]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and ranking among the top securities litigation firms in the U.S. [4].

Core Viewpoint - A securities fraud lawsuit has been filed against Quanex Building Products Corporation and certain executives following disappointing financial results and allegations of misleading investors regarding operational issues at its Tyman facility [1][2][3]. Financial Performance - On September 4, 2025, Quanex reported a diluted EPS of ($6.04), a significant decline from $0.77 in the same quarter the previous year, attributed to ongoing operational issues at the Tyman hardware facility in Mexico [2]. - The company's stock price fell over 23% in two trading days following the earnings announcement [2]. Allegations - The lawsuit claims that Quanex misled investors by not disclosing the poor condition of the Tyman facility, the associated risks, and the negative impact on expected cost savings and integration benefits [3]. Eligibility for Lawsuit - Investors who purchased Quanex common stock between December 12, 2024, and September 5, 2025, and experienced a decline in share value may be eligible to participate in the lawsuit [4]. Next Steps for Investors - The deadline to seek appointment as lead plaintiff is November 18, 2025, and a class has not yet been certified [5]. Whistleblower Information - Individuals with non-public information about Quanex are encouraged to assist in the investigation or file a report with the SEC under the whistleblower program, potentially receiving rewards of up to 30% of any successful recovery [6]. Firm Background - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors and representing many top institutional investors [7].